El suplemento combinado de probiótico Lactiplantibacillus plantarum ECGC 13110402 y esteroles vegetales puede mejorar los lípidos y la microbiota intestinal en adultos con enfermedad celíaca: un estudio piloto de intervención humana aleatorizado y controlado con placebo

also increased in the active group during supplementation. Microbiota analysis revealed potentially beneficial changes in participants receiving the active formulation, including higher alpha diversity and higher proportions of Bifidobacterium spp., Christensenellaceae R-7 group, and Lachnospiraceae ND3007 group. Overall, this feasibility study provides exploratory findings that a combined Lactiplantibacillus plantarum ECGC 13110402-phytosterol formulation may support lipid management and beneficially modulate gut microbiota in adults with CeD, particularly for those seeking non-pharmacological approaches to improving